ABS acquires Cureline

ABS agreed to acquire Cureline. Reported deal value: Undisclosed. Status: Completed. Sector: biotechnology. Target headquarters context: South San Francisco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-01-06. Figures and status may change as filings and press coverage update.

Analytical Biological Services , Inc. , a 3 Boomerang Capital portfolio company and a leader in biospecimen sourcing, cell culture services, and biorepository solutions for the global pharmaceutical and biotechnology industry, has acquired Cureline , Inc. , a leading provider of specimen procurement and histology services to the pharmaceutical and life sciences industries